 |
|
|
| |
Generalised additive model analysis of the relationship between darunavir pharmacokinetics and pharmacodynamics following once-daily darunavir/ ritonavir 800/100mg treatment in the Phase III trials, ARTEMIS and ODIN
|
| |
| |
Reported by Jules Levin
Glasgow 2012 Nov 11-15
Thomas N Kakuda,1 Frank Tomaka,1 Tom Van De Casteele,2 Tony Vangeneugden2
1Janssen Research & Development, LLC, Titusville, NJ, USA; 2Janssen Infectious Diseases BVBA, Beerse, Belgium
|
| |
|
|
|
|
|
